ArticleInternational journal of pharmaceutics2017

Targeting energy metabolism of cancer cells: Combined administration of NCL-240 and 2-DG.

Bhushan S Pattni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.